MedPath

A Randomized Controlled Trial (RCT) of Carbon Dioxide Versus Air Insufflation During Endoscopic Retrograde Cholangiopancreatography (ERCP)

Not Applicable
Completed
Conditions
Cholestasis
Registration Number
NCT00685386
Lead Sponsor
University of North Carolina, Chapel Hill
Brief Summary

The purpose of this study it to conduct a randomized, controlled, double-blinded trial of carbon dioxide (CO2) versus air insufflation during endoscopic retrograde cholangiopancreatography (ERCP).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
74
Inclusion Criteria
  • age >= 18 years
  • referred for ERCP for any indication at UNC Hospitals
Exclusion Criteria
  • age < 18 years
  • COPD requiring oxygen or with known CO2 retention
  • any medical condition with known CO2 retention
  • medical instability making the procedure unsafe
  • absolute requirement for same-day second endoscopy
  • ERCP performed in the OR or under GA
  • inability to read or understand English
  • use of chronic opiates for pain
  • pregnant women

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Abdominal pain (VAS).pre-procedure and up to 24 hours post-procedure.
Secondary Outcome Measures
NameTimeMethod
The extent of CO2 retention.Intra-procedure

Trial Locations

Locations (1)

University of North Carolina-Chapel Hill

🇺🇸

Chapel Hill, North Carolina, United States

University of North Carolina-Chapel Hill
🇺🇸Chapel Hill, North Carolina, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.